Progranulin in neurodegenerative dementia
Authors:
Open Access
- 30 April 2021
- journal article
- review article
- Published by Wiley in Journal of Neurochemistry
- Vol. 158 (2) , 119-137
Abstract
Long‐term or severe lack of protective factors is important in the pathogenesis of neurodegenerative dementia. Progranulin (PGRN), a neurotrophic factor expressed mainly in neurons and microglia, has various neuroprotective effects such as anti‐inflammatory effects, promoting neuron survival and neurite growth, and participating in normal lysosomal function. Mutations in the PGRN gene (GRN) have been found in several neurodegenerative dementias, including frontotemporal lobar degeneration (FTLD) and Alzheimer's disease (AD). Herein, PGRN deficiency and PGRN hydrolytic products (GRNs) in the pathological changes related to dementia, including aggregation of tau and TAR DNA‐binding protein 43 (TDP‐43), amyloid‐β (Aβ) overproduction, neuroinflammation, lysosomal dysfunction, neuronal death, and synaptic deficit have been summarized. Furthermore, as some therapeutic strategies targeting PGRN have been developed in various models, we highlighted PGRN as a potential anti‐neurodegeneration target in dementia. imageKeywords
Funding Information
- National Natural Science Foundation of China (82071478)
This publication has 215 references indexed in Scilit:
- Progranulin: An emerging target for FTLD therapiesBrain Research, 2012
- Strikingly Different Clinicopathological Phenotypes Determined by Progranulin-Mutation DosageThe American Journal of Human Genetics, 2012
- A harmonized classification system for FTLD-TDP pathologyActa Neuropathologica, 2011
- No major progranulin genetic variability contribution to disease etiopathogenesis in an ALS Italian cohortNeurobiology of Aging, 2011
- Progranulin: A promising therapeutic target for rheumatoid arthritisFEBS Letters, 2011
- rs5848 polymorphism and serum progranulin levelJournal of the Neurological Sciences, 2011
- Progranulin Is a Chemoattractant for Microglia and Stimulates Their Endocytic ActivityThe American Journal of Pathology, 2011
- TNF‐mediated inflammatory diseaseThe Journal of Pathology, 2007
- TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's diseaseAnnals of Neurology, 2007
- Hippocampal sclerosis dementia differs from hippocampal sclerosis in frontal lobe degenerationActa Neuropathologica, 2006